Minjuan Hu
241 Huaihai West Rd
Huaihai, 200030, China
Huaihai, 200030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Coinhibition of the MEK/RTK pathway has high therapeutic efficacy in KRAS-mutant non-small cell lung cancer.
Journal: Signal transduction and targeted therapy
Published: February 12, 2025
PEG2000-PLA-based nanoscale polymeric micelles reduce paclitaxel-related toxicity in beagle dogs.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: May 11, 2023
Extracellular vesicle long RNA markers of early-stage lung adenocarcinoma.
Journal: International journal of cancer
Published: July 15, 2022
Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells.
Journal: BMC medical genomics
Published: July 08, 2022
Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma.
Journal: Annals of surgical oncology
Published: January 09, 2022
Local consolidative therapy for synchronous oligometastatic non-small cell lung cancer treated with first-line pembrolizumab: A retrospective observational study.
Journal: Thoracic cancer
Published: November 17, 2021
Pembrolizumab Plus Chemotherapy Versus Chemotherapy Monotherapy as a First-Line Treatment in Elderly Patients (≥75 Years Old) With Non-Small-Cell Lung Cancer.
Journal: Frontiers in immunology
Published: November 02, 2021
Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer patients: A two-year follow-up data update.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: November 02, 2021
The clinicopathological and molecular characteristics of resected EGFR-mutant lung adenocarcinoma.
Journal: Cancer medicine
Published: October 12, 2021
Combined large cell neuroendocrine carcinoma: clinical characteristics, prognosis and postoperative management.
Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Published: July 20, 2021
ctDNA-Profiling-Based UBL Biological Process Mutation Status as a Predictor of Atezolizumab Response Among TP53-Negative NSCLC Patients.
Journal: Frontiers in genetics
Published: June 11, 2021
Last Updated: 09/26/2026